Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
2.1%
1w
3.9%
1m
4.9%
3m
7.6%
6m
8.6%
1y
41.5%
all
11.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 973 2.1%
954
1,248
Company Overview
Sales
345 Cr
Growth: -1.4%
Profit after Tax
87.4 Cr
Growth: -3.6%
Small Cap
2,402 Cr
P/E: 27.5x
Industry P/E: 27.9x
Fundamentals
Sales (Cr) ₹ 345
Growth -1.4%
EBITDA 21.1%
P/S 7.0x
Dividend 1.1%
P/E 27.5x
Book Value ₹ 320
PEG Ratio -19.7x
ROE 11.1%
P/B 3.0x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (4 Indices)
Investors (7)
abdul.ha...
total
bodies.c...